<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Consilium Medicum</journal-id><journal-title-group><journal-title xml:lang="en">Consilium Medicum</journal-title><trans-title-group xml:lang="ru"><trans-title>Consilium Medicum</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>Consilium Medicum</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2075-1753</issn><issn publication-format="electronic">2542-2170</issn><publisher><publisher-name xml:lang="en">Consilium Medicum</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">108442</article-id><article-id pub-id-type="doi">10.26442/20751753.2022.2.201353</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Verifying small vessel disease and mild cognitive impairment with a computational magnetic resonance imaging analysis</article-title><trans-title-group xml:lang="ru"><trans-title>Компьютерный анализ данных магнитно-резонансной томографии головного мозга в верификации болезни мелких сосудов и умеренного когнитивного расстройства</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5203-4497</contrib-id><name-alternatives><name xml:lang="en"><surname>Krupenin</surname><given-names>Pavel M.</given-names></name><name xml:lang="ru"><surname>Крупенин</surname><given-names>Павел Михайлович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Graduate Student, Sechenov First Moscow State Medical University (Sechenov University)</p></bio><bio xml:lang="ru"><p>аспирант каф. нервных болезней и нейрохирургии Института клинической медицины им. Н.В. Склифосовского ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» (Сеченовский Университет)</p></bio><email>krupenin_p_m@student.sechenov.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4741-1988</contrib-id><name-alternatives><name xml:lang="en"><surname>Perepelov</surname><given-names>Vsevolod A.</given-names></name><name xml:lang="ru"><surname>Перепелов</surname><given-names>Всеволод Андреевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Med.), Sechenov First Moscow State Medical University (Sechenov University)</p></bio><bio xml:lang="ru"><p>канд. мед. наук, каф. нервных болезней и нейрохирургии Института клинической медицины им. Н.В. Склифосовского ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» (Сеченовский Университет)</p></bio><email>vsevolod.perepelov@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1951-930X</contrib-id><name-alternatives><name xml:lang="en"><surname>Perepelova</surname><given-names>Elena M.</given-names></name><name xml:lang="ru"><surname>Перепелова</surname><given-names>Елена Михайловна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Med.), Sechenov First Moscow State Medical University (Sechenov University)</p></bio><bio xml:lang="ru"><p>канд. мед. наук, каф. нервных болезней и нейрохирургии Института клинической медицины им. Н.В. Склифосовского ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» (Сеченовский Университет)</p></bio><email>elena_perepelova@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6928-2355</contrib-id><name-alternatives><name xml:lang="en"><surname>Bordovsky</surname><given-names>Sergey P.</given-names></name><name xml:lang="ru"><surname>Бордовский</surname><given-names>Сергей Петрович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Graduate Student, Sechenov First Moscow State Medical University (Sechenov University)</p></bio><bio xml:lang="ru"><p>аспирант каф. нервных болезней и нейрохирургии Института клинической медицины им. Н.В. Склифосовского ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» (Сеченовский Университет)</p></bio><email>sbordoche@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9097-898X</contrib-id><name-alternatives><name xml:lang="en"><surname>Preobrazhenskaya</surname><given-names>Irina S.</given-names></name><name xml:lang="ru"><surname>Преображенская</surname><given-names>Ирина Сергеевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>D. Sci. (Med.), Sechenov First Moscow State Medical University (Sechenov University)</p></bio><bio xml:lang="ru"><p>д-р мед. наук, проф. каф. нервных болезней и нейрохирургии Института клинической медицины им. Н.В. Склифосовского ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» (Сеченовский Университет)</p></bio><email>IrinaSP2@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5938-8917</contrib-id><name-alternatives><name xml:lang="en"><surname>Sokolova</surname><given-names>Anastasiya A.</given-names></name><name xml:lang="ru"><surname>Соколова</surname><given-names>Анастасия Андреевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Med.), Sechenov First Moscow State Medical University (Sechenov University)</p></bio><bio xml:lang="ru"><p>канд. мед. наук, доц. каф. нервных болезней и нейрохирургии Института клинической медицины им. Н.В. Склифосовского ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» (Сеченовский Университет)</p></bio><email>sokolovastasya2@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6241-2711</contrib-id><name-alternatives><name xml:lang="en"><surname>Napalkov</surname><given-names>Dmitry A.</given-names></name><name xml:lang="ru"><surname>Напалков</surname><given-names>Дмитрий Александрович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>D. Sci. (Med.), Sechenov First Moscow State Medical University (Sechenov University)</p></bio><bio xml:lang="ru"><p>д-р мед. наук, проф. каф. нервных болезней и нейрохирургии Института клинической медицины им. Н.В. Склифосовского ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» (Сеченовский Университет)</p></bio><email>dminap@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7330-633X</contrib-id><name-alternatives><name xml:lang="en"><surname>Voskresenskaya</surname><given-names>Olga N.</given-names></name><name xml:lang="ru"><surname>Воскресенская</surname><given-names>Ольга Николаевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>D. Sci. (Med.), Sechenov First Moscow State Medical University (Sechenov University)</p></bio><bio xml:lang="ru"><p>д-р мед. наук, проф. каф. нервных болезней и нейрохирургии Института клинической медицины им. Н.В. Склифосовского ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» (Сеченовский Университет)</p></bio><email>vos-olga@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Sechenov First Moscow State Medical University (Sechenov University)</institution></aff><aff><institution xml:lang="ru">ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет)</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2022-02-15" publication-format="electronic"><day>15</day><month>02</month><year>2022</year></pub-date><volume>24</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>90</fpage><lpage>95</lpage><history><date date-type="received" iso-8601-date="2022-06-01"><day>01</day><month>06</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-06-01"><day>01</day><month>06</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2022, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2022, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://consilium.orscience.ru/2075-1753/article/view/108442">https://consilium.orscience.ru/2075-1753/article/view/108442</self-uri><abstract xml:lang="en"><p><bold>Aim. </bold>To illustrate capabilities of the computational brain мagnetic resonance imaging (MRI) analyses on a small vessel disease (SVD) sample.</p> <p><bold>Materials and methods.</bold> Thirty-one patients underwent brain MRI in standard sequences. We used Lesion Segmentation Tool to assess white matter hyperintensities (WMH) volume and Computational Anatomy Toolbox to calculate cortical thickness. Both software plug-ins work within the Statistical Parametric Mapping 12 software for MATLAB. We also performed cognitive testing with the Montreal Cognitive Assessment test and tests to detect hippocampal and executive domain dysfunction.</p> <p><bold>Results. </bold>Sixteen patients had mild vascular cognitive impairment. The Median Fazekas scale score was 2 and 2 points. The median intracranial volume fraction occupied by the WMH was 0.07%. It correlated with the executive domain performance but not with cortical thickness. Cortical thickness within several clusters of the prefrontal complex and temporal lobe correlated with performance in cognitive tests. Among the computed MRI markers of the SVD, the occipital lobe cortical thickness had an area under the curve of 70%, and among the cognitive tests, the cued recall measure had an area under the curve of 73.8% to detect mild cognitive impairment.</p> <p><bold>Conclusion. </bold>The abovementioned metrics is a valuable tool to objectively estimate white and grey matter state in patients with small vessel disease. Performing those analyses helped to assess SVD properties in the sample further and register new correlations between MRI and cognitive markers.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Цель. </bold>Изучить возможности методов компьютерного анализа данных магнитно-резонансной томографии (МРТ) головного мозга у пациентов с болезнью мелких сосудов (БМС).</p> <p><bold>Материалы и методы. </bold>Обследован 31 пациент с БМС на фоне фибрилляции предсердий. Данные МРТ в стандартных режимах изучены с применением подходов сегментации очагов (Lesion Segmentation Tool) гиперинтенсивного белого вещества (ГИБВ) и расчета толщины коры больших полушарий в Computational Anatomy Toolbox для Statistical Parametric Mapping 12 (пакет программного обеспечения) в среде MATLAB. Оценку когнитивного статуса осуществляли при помощи Монреальской шкалы оценки когнитивных функций (Montreal Cognitive Assessment) и батареи тестов для объективизации гиппокампальных расстройств и нарушений управляющего домена когнитивных функций.</p> <p><bold>Результаты. </bold>У 16 (52%) пациентов диагностировано умеренное когнитивное расстройство сосудистого генеза. Медианное значение по визуальной шкале Фазекас составило 2 и 2 балла, медианная доля внутричерепного объема, занимаемая фракцией ГИБВ – 0,07%. Доля внутричерепного объема, занимаемая ГИБВ, коррелировала с производительностью в тестах управляющего домена. Толщина коры ряда кластеров префронтального комплекса и височной извилины коррелировала с результатами когнитивного тестирования. Среди расчетных МР-маркеров БМС наибольшей положительной предиктивной ценностью в отношении умеренного когнитивного расстройства обладала толщина коры затылочной доли с площадью под кривой, составившей 70%; среди когнитивных тестов – вспоминание с категориальной подсказкой, площадь под кривой 3,8%.</p> <p><bold>Заключение. </bold>Полученные данные могут служить валидным инструментом для оценки характеристик белого и серого вещества головного мозга и установления ряда закономерностей когнитивного функционирования у пациентов с БМС.</p></trans-abstract><kwd-group xml:lang="en"><kwd>small vessel disease</kwd><kwd>mild cognitive impairment</kwd><kwd>computational magnetic resonance analysis</kwd><kwd>cortical thickness</kwd><kwd>white matter hyperintensities</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>болезнь мелких церебральных сосудов</kwd><kwd>умеренное когнитивное расстройство</kwd><kwd>компьютерные методы анализа данных магнитно-резонансной томографии</kwd><kwd>толщина коры</kwd><kwd>гиперинтенсивность белого вещества</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Fazekas F, Chawluk JB, Alavi A, et al. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol. 1987;149(2):351-6. DOI:10.2214/ajr.149.2.351</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Wahlund LO, Barkhof F, Fazekas F, et al. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke. 2001;32(6):1318-22. DOI:10.1161/01.STR.32.6.1318</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Serag D, Ragab E. Bi-caudate ratio as a MRI marker of white matter atrophy in multiple sclerosis and ischemic leukocencephalopathy. Egypt J Radiol Nucl Med. 2019;50(1):99. DOI:10.1186/s43055-019-0104-x</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>DeCarli C, Fletcher E, Ramey V, et al. Anatomical mapping of white matter hyperintensities (WMH): Exploring the relationships between periventricular WMH, deep WMH, and total WMH burden. Stroke. 2005;36(1):50-5. DOI:10.1161/01.STR.0000150668.58689.f2</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Griffanti L, Jenkinson M, Suri S, et al. Classification and characterization of periventricular and deep white matter hyperintensities on MRI: A study in older adults. Neuroimage. 2018;170:174-81. DOI:10.1016/j.neuroimage.2017.03.024</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Sachdev PS, Blacker D, Blazer DG, et al. Classifying neurocognitive disorders: The DSM-5 approach. Nat Rev Neurol. 2014;10(11):634-42. DOI:10.1038/nrneurol.2014.181</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: A Brief Screening. J Am Geriatr Soc. 2005;53(4):695-9. DOI:10.1111/j.1532-5415.2005.53221.x</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Sarazin M, Berr C, De Rotrou J, et al. Amnestic syndrome of the medial temporal type identifies prodromal AD: A longitudinal study. Neurology. 2007;69(19):1859-67. DOI:10.1212/01.wnl.0000279336.36610.f7</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Reitan RM, Wolfson D. The Halstead-Reitan neuropsychological test battery: Theory and clinical interpretation. Tucson, AZ: Neuropsychology Press, 1985.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Smith A. Symbol Digit Modalities Test. Los Angeles, CA: Western Psychological Services, 1973.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Mohs RC, Knopman D, Petersen RC, et al. Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer’s Disease Assessment Scale that broaden its scope. The Alzheimer’s Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997;11 Suppl. 2:13-21.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Ferris SH. General measures of cognition. Int Psychogeriatr. 2003;15 Suppl. 1:215-7. DOI:10.1017/S1041610203009220</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Starkstein SE, Mayberg HS, Preziosi TJ, et al. Reliability, validity, and clinical correlates of apathy in Parkinson’s disease. J Neuropsychiatry Clin Neurosci. 1992;4(2):134-9. DOI:10.1176/jnp.4.2.134</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res. 1982-1983;17(1):37-49. DOI:10.1016/0022-3956(82)90033-4</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Schmidt P, Gaser C, Arsic M, et al. An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis. Neuroimage. 2012;59(4):3774-83. DOI:10.1016/j.neuroimage.2011.11.032</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Gaser C, Dahnke R. CAT-A Computational Anatomy Toolbox for the Analysis of Structural MRI Data. 2016. Available at: http://www.neuro.uni-jena.de/hbm2016/GaserHBM2016.pdf. Accessed: 22.04.2022.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Dahnke R, Yotter RA, Gaser C. Cortical thickness and central surface estimation. Neuroimage. 2013;65:336-48. DOI:10.1016/j.neuroimage.2012.09.050</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Yotter RA, Dahnke R, Thompson PM, Gaser C. Topological correction of brain surface meshes using spherical harmonics. Hum Brain Mapp. 2011;32(7):1109-24. DOI:10.1002/hbm.21095</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Desikan RS, Segonne F, Fischl B, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 2006;31(3):968-80. DOI:10.1016/j.neuroimage.2006.01.021</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Glasser MF, Coalson TS, Robinson EC, et al. A multi-modal parcellation of human cerebral cortex. Nature. 2016;536(7615):171-8. DOI:10.1038/nature18933</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Llinas-Regla J, Vilalta-Franch J, Lopez-Pousa S, et al. The Trail Making Test: Association With Other Neuropsychological Measures and Normative Values for Adults Aged 55 Years and Older From a Spanish-Speaking Population-Based Sample. Assessment. 2017;24(2):183-96. DOI:10.1177/1073191115602552</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Zhuang Y, Zeng X, Wang B, et al. Cortical surface thickness in the middle-aged brain with white matter hyperintense lesions. Front Aging Neurosci. 2017;9:225. DOI:10.3389/fnagi.2017.00225</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Wang Y, Yang Y, Wang T, et al. Correlation between White Matter Hyperintensities Related Gray Matter Volume and Cognition in Cerebral Small Vessel Disease. J Stroke Cerebrovasc Dis. 2020;29(12):105275. DOI:10.1016/j.jstrokecerebrovasdis.2020.105275</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Azarpazhooh MR, Hachinski V. Vascular cognitive impairment: A preventable component of dementia. Handb Clin Neurol. 2019;167:377-91. DOI:10.1016/B978-0-12-804766-8.00020-0</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Euston DR, Gruber AJ, McNaughton BL. The Role of Medial Prefrontal Cortex in Memory and Decision Making. Neuron. 2012;76(6):1057-70. DOI:10.1016/j.neuron.2012.12.002</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Jagust W. Imaging the evolution and pathophysiology of Alzheimer disease. Nat Rev Neurosci. 2018;19(11):687-700. DOI:10.1038/s41583-018-0067-3</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Roe JM, Vidal-Pineiro D, Sorensen O, et al. Asymmetric thinning of the cerebral cortex across the adult lifespan is accelerated in Alzheimer’s disease. Nat Commun. 2021;12(1):721. DOI:10.1038/s41467-021-21057-y</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Grambaite R, Selnes P, Reinvang I, et al. Executive Dysfunction in Mild Cognitive Impairment is Associated with Changes in Frontal and Cingulate White Matter Tracts. J Alzheimer’s Dis. 2011;27(2):453-62. DOI:10.3233/JAD-2011-110290</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Tuladhar AM, van Norden AGW, de Laat KF, et al. White matter integrity in small vessel disease is related to cognition. NeuroImage Clin. 2015;7:518-24. DOI:10.1016/j.nicl.2015.02.003</mixed-citation></ref></ref-list></back></article>
